POSC134 Cost-Effectiveness Analysis of Innovative Therapy for Patients with Newly Diagnosed Hormone-Sensitive Metastatic Prostate Cancer
Abstract
Authors
R Pelloux-Prayer P Schiele S Oudard G Gravis F Kleinclauss G Crehange C Hennequin A Morgans L Geoffrois S Limat A Thiery-Vuillemin V Nerich